Security record · archived quarter
AVBP
ArriVent BioPharma, Inc. · Healthcare · Biotechnology
14Tracked holders
+1Δ holders
10.75MShares held
$198.25MReported value
+2New positions
−1Exits
Momentum inputs (comparable managers):
holder breadth +7.7% ·
share flow +30.0% ·
net new positions +7.1%
— formula
Broad accumulation — rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2025
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 67 | +6 | 17.31M | $600.66M | +10 | −4 |
| Q1 2026 | 63 | +7 | 15.17M | $349.66M | +10 | −3 |
| Q4 2025 | 56 | +3 | 14.51M | $292.04M | +3 | — |
| Q3 2025 | 14 | +1 | 10.75M | $198.25M | +2 | −1 |
| Q2 2025 | 10 | 0 | 7.02M | $152.80M | +2 | −2 |
| Q1 2025 | 7 | +1 | 1.69M | $31.28M | +2 | −1 |
| Q4 2024 | 6 | -1 | 1.52M | $40.62M | +1 | −2 |
| Q3 2024 | 6 | +4 | 925.82K | $21.76M | +4 | — |
| Q2 2024 | 2 | — | 247.05K | $4.58M | — | — |
Who holds it · Q3 2025
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 3.41M | +65.6% | $62.87M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 3.41M | +65.6% | $62.87M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | BlackRock ✦ (passive) | 2.05M | +11.3% | $37.75M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | BlackRock ✦ (passive) | 2.05M | +11.3% | $37.75M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | BlackRock ✦ (passive) | 2.05M | +11.3% | $37.75M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | BlackRock ✦ (passive) | 2.05M | +11.3% | $37.75M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | BlackRock ✦ (passive) | 2.05M | +11.3% | $37.75M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | BlackRock ✦ (passive) | 2.05M | +11.3% | $37.75M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | BlackRock ✦ (passive) | 2.05M | +11.3% | $37.75M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | BlackRock ✦ (passive) | 2.05M | +11.3% | $37.75M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | BlackRock ✦ (passive) | 2.05M | +11.3% | $37.75M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | BlackRock ✦ (passive) | 2.05M | +11.3% | $37.75M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | BlackRock ✦ (passive) | 2.05M | +11.3% | $37.75M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | The Vanguard Group ✦ (passive) | 2.03M | +36.8% | $37.44M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | The Vanguard Group ✦ (passive) | 2.03M | +36.8% | $37.44M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | The Vanguard Group ✦ (passive) | 2.03M | +36.8% | $37.44M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | The Vanguard Group ✦ (passive) | 2.03M | +36.8% | $37.44M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | The Vanguard Group ✦ (passive) | 2.03M | +36.8% | $37.44M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | State Street Global Advisors ✦ (passive) | 1.03M | +38.7% | $18.96M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 20 | Geode Capital Management ✦ (passive) | 716.29K | +20.2% | $13.22M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 21 | Geode Capital Management ✦ (passive) | 716.29K | +20.2% | $13.22M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 22 | Goldman Sachs Group ✦ | 431.94K | — | $7.97M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Goldman Sachs Group ✦ | 431.94K | — | $7.97M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Morgan Stanley ✦ | 392.02K | — | $7.23M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Morgan Stanley ✦ | 392.02K | — | $7.23M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Morgan Stanley ✦ | 392.02K | — | $7.23M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Morgan Stanley ✦ | 392.02K | — | $7.23M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Morgan Stanley ✦ | 392.02K | — | $7.23M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Morgan Stanley ✦ | 392.02K | — | $7.23M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Morgan Stanley ✦ | 392.02K | — | $7.23M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Millennium Management ✦ | 286.10K | +62.4% | $5.28M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 32 | Marshall Wace ✦ | 180.22K | New | $3.33M | 0.0% | New | 1 | SEC ↗ |
| 33 | Marshall Wace ✦ | 180.22K | New | $3.33M | 0.0% | New | 1 | SEC ↗ |
| 34 | Marshall Wace ✦ | 180.22K | New | $3.33M | 0.0% | New | 1 | SEC ↗ |
| 35 | Two Sigma Investments ✦ | 91.72K | New | $1.69M | 0.0% | New | 1 | SEC ↗ |
| 36 | Wellington Management ✦ | 81.75K | +23.2% | $1.51M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 37 | Wellington Management ✦ | 81.75K | +23.2% | $1.51M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 38 | Wellington Management ✦ | 81.75K | +23.2% | $1.51M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 39 | JPMorgan Chase ✦ | 27.98K | — | $516,268 | 0.0% | n/c | 1 | SEC ↗ |
| 40 | JPMorgan Chase ✦ | 27.98K | — | $516,268 | 0.0% | n/c | 1 | SEC ↗ |
| 41 | JPMorgan Chase ✦ | 27.98K | — | $516,268 | 0.0% | n/c | 1 | SEC ↗ |
| 42 | JPMorgan Chase ✦ | 27.98K | — | $516,268 | 0.0% | n/c | 1 | SEC ↗ |
| 43 | JPMorgan Chase ✦ | 27.98K | — | $516,268 | 0.0% | n/c | 1 | SEC ↗ |
| 44 | JPMorgan Chase ✦ | 27.98K | — | $516,268 | 0.0% | n/c | 1 | SEC ↗ |
| 45 | T. Rowe Price ✦ | 14.36K | +25.3% | $265,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 46 | AQR Capital Management ✦ | 11.82K | -17.5% | $218,134 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 47 | AQR Capital Management ✦ | 11.82K | -17.5% | $218,134 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 48 | AQR Capital Management ✦ | 11.82K | -17.5% | $218,134 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 49 | AQR Capital Management ✦ | 11.82K | -17.5% | $218,134 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 50 | AQR Capital Management ✦ | 11.82K | -17.5% | $218,134 | 0.0% | ▼ Trim | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Marshall Wace | $3.33M | 0.0% |
| Marshall Wace | $3.33M | 0.0% |
| Marshall Wace | $3.33M | 0.0% |
| Two Sigma Investments | $1.69M | 0.0% |
Exited
| Citadel Advisors | $732,669 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 138 holders, 42.02M shares, $965.37M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q3 2025 ·
Methodology ·
Get this via the API